Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27909198 | 0.81 | — | — | |
| SCHEMBL27764152 | 0.78 | — | — | |
| SCHEMBL27714946 | 0.78 | MEN1 (0.36) | — | |
| SCHEMBL28807139 | 0.74 | MGLL (0.31) | — | |
| SCHEMBL27908096 | 0.74 | MEN1 (0.33) | — | |
| SCHEMBL28775423 | 0.72 | MEN1 (0.30) | — | |
| SCHEMBL27679469 | 0.68 | LMNA (0.36) | — | |
| SCHEMBL27926995 | 0.68 | — | — | |
| SCHEMBL28036513 | 0.68 | MEN1 (0.34) | — | |
| SCHEMBL27534850 | 0.68 | JAK2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101448822-B | Substituted pyrazolopyrimidines | CEPHALON INC | 2013-11-06 | — | — | CN | disclosed |
| CN-102241680-A | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | IRM LLC | 2011-11-16 | — | — | CN | disclosed |
| CN-101048408-B | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | IRM LLC | 2011-07-06 | — | — | CN | disclosed |
| CN-101454327-A | Azolopyrimidines as inhibitors of cannabinoid 1 activity | IRM LLC (BM) | 2009-06-10 | — | — | CN | disclosed |
| CN-101448822-A | Substituted pyrazolopyrimidines | KYOCERA CORP (US) | 2009-06-03 | — | — | CN | disclosed |
| CN-101048408-A | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | IRM LLC (BM) | 2007-10-03 | — | — | CN | disclosed |